BIOMAT Database Logo BIOMAT Database Logo

Abnormalities of the complement system in Reye syndrome. 1979

R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin

Sixteen patients with Reye syndrome had diminished concentration of serum complement proteins and/or hemolytic activity in the earliest blood sample. All 12 studied with hemolytic methods had significantly reduced C1 activity; total hemolytic complement activity was reduced in only three. Low Cl activity was accompanied by equivalent reduction of Cls in 11 of 12 patients; Clq was less than normal in only two of 12. Decreased levels of at least one other classical pathway complement hemolytic activity or protein concentration were found in 13 patients, whereas factor B or the alternate complement pathway was normal or elevated in the ten patients studied. The consistent reduction of Cls protein concentration in Reye syndrome suggests that early metabolic abnormalities regularly affect the production or catabolism of this protein. Although normal serum Clq concentration in the majority of these patients does not support an immune pathogenesis, decreased Clq, C4, and C2 in three patients does suggest that immune mechanisms may be responsible for the serum complement abnormalities in this latter group of patients.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003171 Complement Pathway, Classical Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Classical Complement Pathway,Classical Complement Activation Pathway,Complement Activation Pathway, Classical
D003172 Complement C1 The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION. C1 Complement,Complement 1,Complement Component 1,C1, Complement,Complement, C1,Component 1, Complement
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012202 Reye Syndrome A form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism. Fatty Liver with Encephalopathy,Reye Syndrome, Adult,Reye's Syndrome,Reye's Syndrome, Adult,Reye's-Like Syndrome,Reye-Johnson Syndrome,Reye-Like Syndrome,Adult Reye Syndrome,Adult Reye's Syndrome,Reye Johnson Syndrome,Reye Like Syndrome,Reye's Like Syndrome

Related Publications

R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
Severe coagulation abnormalities in Reye syndrome.
September 1977, The Journal of pediatrics,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
EEG correlations with biochemical abnormalities in Reye syndrome.
February 1977, Archives of neurology,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
The National Reye Syndrome Surveillance System, 1983.
January 1984, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
Reye syndrome and reye-like syndrome.
September 2008, Pediatric neurology,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
[Reye syndrome and Reye-like syndrome].
March 2011, Nihon rinsho. Japanese journal of clinical medicine,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
April 2011, La Revue de medecine interne,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
[The Reye syndrome].
March 2011, Journal de pharmacie de Belgique,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
[Reye syndrome].
July 1988, Kinderarztliche Praxis,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
Reye syndrome.
October 1978, Annals of neurology,
R J Pickering, and R E Urizar, and P A Hanson, and R J Laffin
Reye syndrome.
July 2003, The American journal of nursing,
Copied contents to your clipboard!